{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:13:54Z","timestamp":1792131234346,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.psychres.2023.115135","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:10:04Z","timestamp":1677582604000},"page":"115135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders \u2013 Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study"],"prefix":"10.1016","volume":"323","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7181-7419","authenticated-orcid":false,"given":"Kirsten R.","family":"M\u00fcller-Vahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pisarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Szejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Fremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewgeni","family":"Jakubovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Musil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3219-2284","authenticated-orcid":false,"given":"Alexander","family":"M\u00fcnchau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Neuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9124-4128","authenticated-orcid":false,"given":"Daniel","family":"Huys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger Tebartz","family":"van Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-3216","authenticated-orcid":false,"given":"Rieke","family":"Ringlstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Beate","family":"Jenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1455-2474","authenticated-orcid":false,"given":"Anika","family":"Gro\u00dfhennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2023.115135_bib0001","article-title":"A double-blind, randomized, controlled crossover trial of cannabis in adults with Tourette syndrome","author":"Abi-Jaoude","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.psychres.2023.115135_bib0002","first-page":"1","article-title":"Sex differences in patients with Tourette syndrome","author":"Baizabal-Carvallo","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psychres.2023.115135_bib0003","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2004.01.005","article-title":"[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after \u03949-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in Tourette patients","volume":"55","author":"Berding","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173107","article-title":"Sex differences and the endocannabinoid system in pain","volume":"202","author":"Blanton","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2023.115135_bib0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2017.05.005","article-title":"Cannabinoids in attention-deficit\/hyperactivity disorder: a randomised-controlled trial","volume":"27","author":"Cooper","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115135_bib0006","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/pm\/pnab050","article-title":"Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials","volume":"22","author":"Dykukha","year":"2021","journal-title":"Pain Med."},{"key":"10.1016\/j.psychres.2023.115135_bib0007","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bph.15302","article-title":"Different responses of repetitive behaviours in juvenile and young adult mice to \u0394 9 -tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome","volume":"178","author":"Gorberg","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2023.115135_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.626459","article-title":"Yale global tic severity scale (YGTSS): psychometric quality of the gold standard for tic assessment based on the large-scale EMTICS study","volume":"12","author":"Haas","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.575826","article-title":"The CANNA-TICS study protocol: a randomized multi-center double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders","volume":"11","author":"Jakubovski","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cct.2013.08.012","article-title":"Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods","volume":"36","author":"Jeon","year":"2013","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.psychres.2023.115135_bib0011","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0012","article-title":"Treatment failure in persistent tic disorders: an expert clinicians\u2019 consensus-based definition","author":"Martino","year":"2021","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2018.0050","article-title":"Treatment of Gilles de la Tourette syndrome with cannabis-based medicine: results from a retrospective analysis and online survey","volume":"4","author":"Milosev","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.psychres.2023.115135_bib0014","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis","volume":"192","author":"Morgan","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study","volume":"197","author":"Morgan","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0016","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41386-020-0671-6","article-title":"Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome","volume":"45","author":"M\u00fcller-Vahl","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2023.115135_bib0017","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.28681","article-title":"Monoacylglycerol lipase inhibition in Tourette syndrome: a 12-week, randomized, controlled study","volume":"36","author":"M\u00fcller-Vahl","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.psychres.2023.115135_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.793703","article-title":"Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial","volume":"16","author":"M\u00fcller-Vahl","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psychres.2023.115135_bib0019","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00787-021-01832-4","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders: summary statement","volume":"31","author":"M\u00fcller-Vahl","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of tourette's syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458511419700","article-title":"A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex\u00ae (nabiximols)","volume":"18","author":"Notcutt","year":"2012","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.psychres.2023.115135_bib0023","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00004714-198812000-00021","article-title":"Marijuana and Tourette??s syndrome","volume":"8","author":"Sandyk","year":"1988","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2023.115135_bib0024","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/0883073819862121","article-title":"Controversies surrounding the pathophysiology of tics","volume":"34","author":"Singer","year":"2019","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.psychres.2023.115135_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.00125","article-title":"Association of a variant of CNR1 gene encoding cannabinoid receptor 1 with gilles de la Tourette syndrome","volume":"11","author":"Szejko","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.psychres.2023.115135_bib0026","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00787-021-01842-2","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders\u2014version 2.0. Part I: assessment","volume":"31","author":"Szejko","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115135_bib0027","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jat\/bkx012","article-title":"Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes","volume":"41","author":"Vandrey","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.psychres.2023.115135_bib0028","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders \u2013 efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2023.115135_bib0029","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopsych.2020.12.028","article-title":"Investigating shared genetic basis across Tourette syndrome and comorbid neurodevelopmental disorders along the impulsivity-compulsivity spectrum","volume":"90","author":"Yang","year":"2021","journal-title":"Biol. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:56:54Z","timestamp":1759039014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":29,"alternative-id":["S0165178123000860"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115135","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders \u2013 Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115135"}}